Published in Haemophilia on July 05, 2012
Kidney and Liver Transplantation in People With HIV | NCT00074386
ATHN 11: Liver Transplantation Outcomes Study (HOT) | NCT04055051
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet (2003) 4.88
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl (2012) 4.65
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50
HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology (2005) 2.42
Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology (2010) 2.30
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol (2005) 2.27
Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis (2003) 2.17
Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl (2005) 1.79
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Liver Transpl (2009) 1.65
HIV increases HCV replication in a TGF-beta1-dependent manner. Gastroenterology (2008) 1.60
Are HIV-infected patients candidates for liver transplantation? J Hepatol (2008) 1.59
Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl (2004) 1.58
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology (2008) 1.47
Hepatitis and clotting-factor concentrates. JAMA (1972) 1.44
Reasons for stopping antiretrovirals used in an initial highly active antiretroviral regimen: increased incidence of stopping due to toxicity or patient/physician choice in patients with hepatitis C coinfection. AIDS Res Hum Retroviruses (2005) 1.34
Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J Infect Dis (2001) 1.30
Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant (2006) 1.26
Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages. Immunology (2005) 1.15
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology (2009) 1.11
Suppression of hepatitis C virus replicon by TGF-beta. Virology (2005) 1.05
Highly active antiretroviral therapy improves ESLD-free survival in HIV-HCV co-infection. Haemophilia (2009) 0.96
The Institute of Medicine report on viral hepatitis: a call to action. Hepatology (2010) 0.94
Liver transplantation in HIV-infected recipients. Semin Liver Dis (2006) 0.90
Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection. Liver Transpl (2009) 0.82
Liver transplantation in HIV/hepatitis co-infection. J HIV Ther (2007) 0.81
Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophilia. Haemophilia (2010) 0.81
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med (1991) 8.65
Kidney transplantation under FK 506. JAMA (1990) 7.45
Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med (2000) 6.65
Essential role for oncogenic Ras in tumour maintenance. Nature (1999) 6.51
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92
Epidemiological assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol (2001) 4.94
In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrob Agents Chemother (1986) 4.51
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
Condoms prevent transmission of AIDS-associated retrovirus. JAMA (1986) 3.78
Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol (1998) 3.51
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Novel endotheliotropic herpesviruses fatal for Asian and African elephants. Science (1999) 3.30
Prevalence of child physical and sexual abuse in the community. Results from the Ontario Health Supplement. JAMA (1997) 3.24
Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nat Med (1997) 3.03
Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet (1999) 3.01
Analgesic efficacy of ultrasound-guided transversus abdominis plane block in patients undergoing open appendicectomy. Br J Anaesth (2009) 2.83
Allospecificity of activated T cells grown from endomyocardial biopsies from heart transplant patients. Transplantation (1986) 2.82
Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat Genet (1997) 2.81
Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol (1995) 2.69
Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure. Am J Transplant (2014) 2.67
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet (1990) 2.66
The prognostic value of kidney transplant center report cards. Am J Transplant (2013) 2.64
Identification and characterization of a family of Rab11-interacting proteins. J Biol Chem (2001) 2.64
Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone (2003) 2.51
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50
Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA (1999) 2.36
Mechanism of indinavir-induced hyperbilirubinemia. Proc Natl Acad Sci U S A (2001) 2.32
The 5'-proximal region of the wheat Cab-1 gene contains a 268-bp enhancer-like sequence for phytochrome response. EMBO J (1987) 2.31
The effects of FK 506 on renal function after liver transplantation. Transplant Proc (1990) 2.31
FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29
One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry (1996) 2.18
Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. Transplant Proc (1990) 2.15
FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. Transplantation (1990) 2.13
Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology (2000) 2.09
In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci. Antimicrob Agents Chemother (1999) 2.08
Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant (2005) 2.07
Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab. Am J Transplant (2010) 2.06
Intracerebral metastases in solid-tumor patients: natural history and results of treatment. Cancer (1981) 2.05
Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. Am J Transplant (2015) 2.03
Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology (1987) 2.03
Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis. Transpl Infect Dis (2015) 2.00
Countercurrent immunoelectrophoresis of urine as well as of CSF and blood for diagnosis of bacterial meningitis. J Pediatr (1976) 2.00
Role of murein lipoprotein in morphogenesis of the bacterial division septum: phenotypic similarity of lkyD and lpo mutants. J Bacteriol (1978) 1.94
Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood (1990) 1.93
Hormonal control of the renal conversion of 25-hydroxycholecalciferol to 1,25-dihydroxycholecalciferol. J Clin Invest (1972) 1.93
Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial. Arch Surg (2000) 1.89
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. Am J Transplant (2012) 1.88
Size and motion of the mitral valve annulus in man. I. A two-dimensional echocardiographic method and findings in normal subjects. Circulation (1981) 1.88
Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg (1992) 1.85
Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment. Arthritis Rheum (1995) 1.82
Phytochrome activation of two nuclear genes requires cytoplasmic protein synthesis. EMBO J (1989) 1.81
Outcome of preimplantation genetic diagnosis of translocations. Fertil Steril (2000) 1.78
Monitoring and treatment of intestinal allograft rejection in humans. Transplant Proc (1993) 1.78
Laparoscopic complications in markedly obese urologic patients (a multi-institutional review) Urology (1996) 1.75
Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc (1991) 1.75
Small intestinal transplantation in humans with or without the colon. Transplantation (1994) 1.74
Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. J Clin Invest (2001) 1.73
The relation between heat produced and phosphorylcreatine split during isometric contraction of frog's muscle. J Physiol (1967) 1.71
Use of a rapid test of pneumococcal colonization density to diagnose pneumococcal pneumonia. Clin Infect Dis (2011) 1.70
Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am J Transplant (2007) 1.69
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. Transplant Proc (1991) 1.69
EMG responses to maintain stance during multidirectional surface translations. J Neurophysiol (1998) 1.67
Stability assessment of distal radius fractures. Injury (1989) 1.67
Clinical and pathological findings of a newly recognized disease of elephants caused by endotheliotropic herpesviruses. J Wildl Dis (2000) 1.66
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group. J Infect Dis (1998) 1.64
Rapid detection of microbial contamination in frozen vegetables by automated impedance measurements. Appl Environ Microbiol (1977) 1.63
The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc (1991) 1.60
Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. J Infect Dis (2006) 1.60
PCR primers for human chromosomes: reagents for the rapid analysis of somatic cell hybrids. Genomics (1991) 1.58
Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study. J Infect Dis (2001) 1.58
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56
Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology (2006) 1.56
Stimulation of aggrecan synthesis in cartilage explants by cyclic loading is localized to regions of high interstitial fluid flow. Arch Biochem Biophys (1999) 1.56
Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant (2006) 1.55
Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. Am J Transplant (2013) 1.54
Abnormal homicide in Hong Kong. Br J Psychiatry (1973) 1.50
OPTN/SRTR 2011 Annual Data Report: liver. Am J Transplant (2013) 1.48
Skills training for pregnancy and AIDS prevention in Anglo and Latino youth. J Adolesc Health (1998) 1.48
HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver? J Viral Hepat (2008) 1.45
Prevalence of antibody to hepatitis C virus in patients infected with the human immunodeficiency virus. J Infect Dis (1991) 1.45
Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg (2001) 1.44
Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44
Cavitary Legionella pneumonia in a liver transplant recipient. Transpl Infect Dis (2004) 1.43
Intestinal transplantation at the University of Pittsburgh. Transplant Proc (1994) 1.42
The International Sanitary Convention of 1944. Proc R Soc Med (1945) 1.41
Optimizing the program-specific reporting of pancreas transplant outcomes. Am J Transplant (2013) 1.40
A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation. Transplant Proc (1991) 1.40
Safe paediatric neurosurgery 2001. Br J Neurosurg (2002) 1.40
Control of stance during lateral and anterior/posterior surface translations. IEEE Trans Rehabil Eng (1998) 1.39
Ring chromosome 14: a distinct clinical entity. J Med Genet (1981) 1.39
Adalimumab-induced asthma. Rheumatology (Oxford) (2005) 1.38
Long-term results of electrophysiologically guided sotalol therapy for life-threatening ventricular arrhythmias. Am Heart J (1996) 1.38
BK virus replication and nephropathy after alemtuzumab-induced kidney transplantation. Am J Transplant (2012) 1.38
Rifampicin antibiotic impregnation of the St. Jude Medical mechanical valve sewing ring: a weapon against endocarditis. J Thorac Cardiovasc Surg (1996) 1.38